Brawn Biotech appoints new statutory auditor, re-appoints director
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.3 pts more than Nifty Microcap 250 and 5.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Brawn Biotech shareholders approved two resolutions at the AGM: appointment of M/s GDSM and Co Chartered Accountants (FRN 034194N) as new Statutory Auditors for a five-year term till FY 2030-31, effective 29 September 2026, and re-appointment of Mr. Brij Raj Gupta as Director, who retired by rotation. Mr. Gupta has been associated with the company since November 1985 and holds about 5 lakh equity shares.
New auditor kicks off a fresh five-year audit cycle, while the long-serving director continues, pointing to stable leadership and standard governance housekeeping.